跳至主要内容
临床试验/NCT04859816
NCT04859816已完成不适用

Fat Absorption and Metabolism After Roux-en-Y Gastric Bypass

Hvidovre University Hospital1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2021年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
24
试验地点
1
主要终点
Area under the curve of plasma triacylglycerol

研究概览

简要总结

Using intravenous and oral administration of stable isotope tracers, we will investigate the importance of altered fat absorption and altered whole body fat metabolism for the reduced postprandial systemic TAG concentrations in non-diabetic patients in weight stable phase after RYGB.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age > 18 years
  • •RYGB > 12 months prior to inclusion
  • •Weight stable (± 3 kg during the last month)
  • •HbA1c < 48 mmol/mol before surgery, and no history of diabetes
  • •HbA1c < 48 mmol/mol and fasting plasma glucose < 6.1 mmol/l at inclusion
  • •Inclusion criteria, CON
  • •Age > 18 years
  • •No former bariatric surgery
  • •Weight stable (± 3 kg during the last month)
  • •HbA1c < 48 mmol/mol, fasting plasma glucose < 6.1, and no history of diabetes

排除标准

  • •Thyrotoxicosis or inadequately treated hypothyreosis
  • •Haemoglobin < 6.5 mmol/l at inclusion
  • •Pregnancy (pregnancy test in fertile woman before enrolment) or breast feeding
  • •Medication affecting the planned examinations which cannot be paused during the study period.
  • •Adherence to extreme diets with excessively high or low contributions from certain macronutrients (e.g. ketogenic diet)
  • •Complications restricting eating behavior (e.g. postprandial hypoglycemia, vomiting or strictures)
  • •MR contraindications

研究组 & 干预措施

Roux-en-Y gastric bypass operated participants

Experimental

Roux-en-Y gastric bypass operated participants in weight stable phase > 1 year from surgery

干预措施: Metabolic test (Other)

Roux-en-Y gastric bypass operated participants

Experimental

Roux-en-Y gastric bypass operated participants in weight stable phase > 1 year from surgery

干预措施: DXA-scan (Other)

Roux-en-Y gastric bypass operated participants

Experimental

Roux-en-Y gastric bypass operated participants in weight stable phase > 1 year from surgery

干预措施: MRS (Other)

Roux-en-Y gastric bypass operated participants

Experimental

Roux-en-Y gastric bypass operated participants in weight stable phase > 1 year from surgery

干预措施: Feces collection (Other)

Control participants

Experimental

Age, sex, and BMI-matched un-operated participants.

干预措施: Metabolic test (Other)

Control participants

Experimental

Age, sex, and BMI-matched un-operated participants.

干预措施: DXA-scan (Other)

Control participants

Experimental

Age, sex, and BMI-matched un-operated participants.

干预措施: MRS (Other)

Control participants

Experimental

Age, sex, and BMI-matched un-operated participants.

干预措施: Feces collection (Other)

结局指标

主要结局

Area under the curve of plasma triacylglycerol

时间窗: 6 hours

During a high-fat liquid mixed meal test

次要结局

  • Recovery of oral stable triacylglycerol isotope tracer in feces(4 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Morten Gadegaard Hindsø, MD

Principal Investigator

Hvidovre University Hospital

研究点 (1)

Loading locations...

相似试验